Early Removal of Ureteral Stent After Kidney Transplant Could Decrease Incidence of Urinary Tract Infection: A Systematic Review and Meta-Analysis

Wang, Yunhan; Yang, Yue; Zhang, Hanchao; Wang, Yang

doi:10.6002/ect.2021.0183

Cited by 3 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Over time, the presence of a stent in the body increases the risk of urinary tract infection and the rate of surface crust formation ( Klis et al, 2009 ; El-Hayek et al, 2017 ). In a recent meta-analysis, the early removal of ureteral stents (i.e., within 3 weeks) was found to significantly mitigate the occurrence of urinary tract infections ( Wang et al, 2022 ). Undoubtedly, the combination of the primary disease and the adverse effects associated with the use of ureteral stents places a significant financial burden on global healthcare systems, presenting substantial challenges to their fiscal resources and long-term sustainability.…”

Section: Introductionmentioning

confidence: 99%

Recent development and future application of biodegradable ureteral stents

Hu,

Hou,

Huang

et al. 2024

Front. Bioeng. Biotechnol.

View full text Add to dashboard Cite

Ureteral stenting is a common clinical procedure for the treatment of upper urinary tract disorders, including conditions such as urinary tract infections, tumors, stones, and inflammation. Maintaining normal renal function by preventing and treating ureteral obstruction is the primary goal of this procedure. However, the use of ureteral stents is associated with adverse effects, including surface crusting, bacterial adhesion, and lower urinary tract symptoms (LUTS) after implantation. Recognizing the need to reduce the complications associated with permanent ureteral stent placement, there is a growing interest among both physicians and patients in the use of biodegradable ureteral stents (BUS). The evolution of stent materials and the exploration of different stent coatings have given these devices different roles tailored to different clinical needs, including anticolithic, antibacterial, antitumor, antinociceptive, and others. This review examines recent advances in BUS within the last 5 years, providing an in-depth analysis of their characteristics and performance. In addition, we present prospective insights into the future applications of BUS in clinical settings.

show abstract

Section: Introductionmentioning

confidence: 99%

Recent development and future application of biodegradable ureteral stents

Hu,

Hou,

Huang

et al. 2024

Front. Bioeng. Biotechnol.

View full text Add to dashboard Cite

show abstract

Evaluation of a Ureteral Stent Removal Protocol in Adult Kidney Transplant Recipients

Krzos,

Nguyen,

Kane

et al. 2024

Open Forum Infectious Diseases

View full text Add to dashboard Cite

Existing literature on best practices to reduce the risk of infectious complications associated with ureteral stent removal in kidney transplant recipients is limited. Prior to 2021, a formal process surrounding stent removal was not in place at our institution. In June 2021, a stent removal protocol was established. This protocol included the following: obtaining a preprocedure urine culture, prescribing universal culture-directed antimicrobial prophylaxis, earlier stent removal posttransplant, and patient education. We performed a retrospective quasi-experimental study of kidney transplant recipients who had their stents removed between July 2020 and June 2022. The primary outcome was the incidence of infectious complications within 30 days. Infectious complications were defined as urinary tract infection and bacteremia due to urinary source, as well as hospitalization, emergency department visit, or outpatient encounter for possible urinary tract infection. Secondary objectives included infectious and immunologic complications within 30 days to 1 year from transplant. During this study period, 239 adult kidney transplant recipients were included: 88 in the preprotocol group and 151 in the protocol group. The median time to stent removal was shorter in the protocol group (25 vs 36 days, P < .001). More patients in the protocol group received preprocedure antibiotics (99% vs 36%, P < .001). Infectious complications were higher in the preprotocol group (9% vs 3%, P = .035). Overall, the stent removal protocol was associated with fewer infectious complications (odds ratio, 0.18; 95% CI, 0.05–0.73). Further investigation is necessary to determine which individual interventions, if any, drive this benefit.

show abstract

Long-Term Complications of Kidney Transplantation

Edwards

Ibrahim

2022

nephsap

View full text Add to dashboard Cite

Early Removal of Ureteral Stent After Kidney Transplant Could Decrease Incidence of Urinary Tract Infection: A Systematic Review and Meta-Analysis

Cited by 3 publications

References 28 publications

Recent development and future application of biodegradable ureteral stents

Recent development and future application of biodegradable ureteral stents

Evaluation of a Ureteral Stent Removal Protocol in Adult Kidney Transplant Recipients

Long-Term Complications of Kidney Transplantation

Contact Info

Product

Resources

About